Tumor Differentiation and EGFR Mutation Associated with Disease-Free Survival in Stage IA Lung Adenocarcinoma Patients with Curative Surgery

BACKGROUND: Nearly 30% of stage IA non-small-cell lung cancer patients eventually die of recurrence or metastasis. This study aimed to predict stage IA lung adenocarcinoma (LADC) patients who underwent radical resection with a high risk of recurrence or metastasis. METHODS: Information on clinicopat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lu, Pang, Chong, Xu, Fei, Yang, Guangjian, Xu, Haiyan, Wang, Changli, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732172/
https://www.ncbi.nlm.nih.gov/pubmed/33324099
http://dx.doi.org/10.2147/CMAR.S286503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732172/
https://www.ncbi.nlm.nih.gov/pubmed/33324099
http://dx.doi.org/10.2147/CMAR.S286503

Ejemplares similares